Literature DB >> 2106377

Effect of heparin on bone formation in cultured fetal rat calvaria.

M M Hurley1, G Gronowicz, B E Kream, L G Raisz.   

Abstract

To assess the effects of heparin on bone formation we measured [3H]proline incorporation into collagenase-digestible (CDP) and noncollagen protein (NCP), [3H]thymidine (TdR) incorporation into DNA, and DNA content in 21-day-old fetal rat calvaria cultured in BGJ medium with bovine serum albumin for 24-96 hours. Heparin at 5-125 micrograms/ml decreased TdR incorporation by 26-51% at 24 and 96 hours. At 96 hours, heparin 5, 25, and 125 micrograms/ml decreased [3H]proline incorporation into CDP by 41, 48, and 32%, respectively, with no significant change in NCP. To evaluate the possible role of PGE2 in these inhibitory responses, media PGE2 concentration was measured and the effects of heparin on CDP labeling and DNA synthesis were tested in the presence of indomethacin, piroxicam, and flurbiprofen to inhibit endogenous prostaglandin E2 (PGE2) production and in the presence of a high concentration (10(-7) M) of exogenous PGE2. Heparin did not alter PGE2 production at 24 hours but at 48 hours there was a significant reduction. At 96 hours, indomethacin (10(-6) M) inhibited [3H]-proline incorporation into CDP by 38% but had no effect on the labeling of NCP. Heparin had no further significant inhibitory effect in the presence of indomethacin. Piroxicam and flurbiprofen did not alter DNA content and had a smaller inhibitory effect than indomethacin on the labeling of CDP. Moreover, addition of heparin produced a further inhibition of CDP and DNA content and finally, heparin decreased CDP labeling by 71% in the presence of PGE2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106377     DOI: 10.1007/bf02555042

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  16 in total

Review 1.  Heparin-induced osteopenia: an appraisal.

Authors:  L V Avioli
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

2.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

3.  Association in normal human fibroblasts of elevated levels of adenosine 3':5'-monophosphate with a selective decrease in collagen production.

Authors:  B J Baum; J Moss; S D Breul; R G Crystal
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

Review 4.  The mast cell and bone.

Authors:  M J McKenna; B Frame
Journal:  Clin Orthop Relat Res       Date:  1985-11       Impact factor: 4.176

5.  Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.

Authors:  J R Guyton; R D Rosenberg; A W Clowes; M J Karnovsky
Journal:  Circ Res       Date:  1980-05       Impact factor: 17.367

6.  Heparin modulates intracellular cyclic AMP in human trabecular bone cells and adherent rheumatoid synovial cells.

Authors:  A J Crisp; M S Roelke; S R Goldring; S M Krane
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

7.  HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE.

Authors:  P GOLDHABER
Journal:  Science       Date:  1965-01-22       Impact factor: 47.728

8.  Effects of parathyroid hormone and cortisol on prostaglandin production by neonatal rat calvaria in vitro.

Authors:  L G Raisz; H A Simmons
Journal:  Endocr Res       Date:  1985       Impact factor: 1.720

9.  Stimulation of bone formation by prostaglandin E2.

Authors:  Y S Chyun; L G Raisz
Journal:  Prostaglandins       Date:  1984-01

10.  Heparin-induced osteoporosis in rats.

Authors:  T Mätzsch; D Bergqvist; U Hedner; B Nilsson; P Ostergaard
Journal:  Thromb Haemost       Date:  1986-12-15       Impact factor: 5.249

View more
  1 in total

1.  Effects of short-term, high dose, heparin therapy on biochemical markers of bone metabolism.

Authors:  F Cantini; L Niccoli; F Bellandi; O Di Munno
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.